MAPS vs CRON

For growth investors, Cronos Group Inc.

(CRON) is the stronger pick with 64. 4% revenue growth year-over-year, versus -5. 3% for WM Technology, Inc. (MAPS). WM Technology, Inc. (MAPS) offers the better valuation at 18. 7x trailing P/E, making it the more compelling value choice. Analysts rate Cronos Group Inc. (CRON) a "Hold" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Cronos Group Inc.

(CRON) delivered a total return of -65. 6%, compared to -97. 7% for WM Technology, Inc. (MAPS). Over 10 years, the gap is even starker: CRON returned +1488% versus MAPS's -96. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), WM Technology, Inc.

(MAPS) is the lower-risk stock at 0. 57β versus Cronos Group Inc. 's 0. 98β — meaning CRON is approximately 72% more volatile than MAPS relative to the S&P 500. On balance sheet safety, Cronos Group Inc. (CRON) carries a lower debt/equity ratio of 0% versus 20% for WM Technology, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Cronos Group Inc.

(CRON) is pulling ahead at 64. 4% versus -5. 3% for WM Technology, Inc. (MAPS). On earnings-per-share growth, the picture is similar: WM Technology, Inc. grew EPS -74. 6% year-over-year, compared to -100. 0% for Cronos Group Inc.. Over a 3-year CAGR, CRON leads at 30. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

WM Technology, Inc.

(MAPS) is the more profitable company, earning 1. 1% net margin versus -4. 9% for Cronos Group Inc. — meaning it keeps 1. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MAPS leads at 0. 4% versus -1. 5% for CRON. At the gross margin level — before operating expenses — MAPS leads at 94. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Cronos Group Inc.

(CRON) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 98), +1488% 10Y return). Both have compounded well over 10 years (CRON: +1488%, MAPS: -96. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (MAPS (Technology) and CRON (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: MAPS is a small-cap quality compounder stock; CRON is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.